Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Operating activities
Net income	$ 53,344	$ 43,982
Adjustments to reconcile net income to net cash provided by operating activities:
Distributions from unconsolidated subsidiaries	7,872	1,364
Depreciation and amortization	52,138	46,771
Provision for bad debts	1,567	85
Equity in earnings of unconsolidated subsidiaries	(4,366)	(4,697)
Loss on extinguishment of debt	0	412
Gain on sale of assets and businesses	(6,233)	(513)
Stock compensation expense	6,255	4,927
Amortization of debt discount, premium and issuance costs	3,231	3,136
Deferred income taxes	(81)	78
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	(74,752)	(45,811)
Other current assets	(7,523)	(8,945)
Other assets	57,319	16,633
Accounts payable	4,324	(6,552)
Accrued expenses	(69,163)	(11,981)
Income taxes	17,830	11,838
Net cash provided by operating activities	41,762	50,727
Investing activities
Business combinations, net of cash acquired	(6,120)	(515,359)
Purchases of property and equipment	(49,073)	(39,617)
Investment in businesses	(27,608)	(1,754)
Proceeds from sale of assets and businesses	2	691
Net cash used in investing activities	(82,799)	(556,039)
Financing activities
Borrowings on revolving facilities	360,000	165,000
Payments on revolving facilities	(220,000)	(150,000)
Proceeds from term loans	0	779,904
Payments on term loans	(132,685)	(2,875)
Revolving facility debt issuance costs	0	(1,333)
Borrowings of other debt	8,290	11,600
Principal payments on other debt	(6,155)	(5,909)
Repurchase of common stock	0	(122)
Dividends paid to Holdings	0	0
Proceeds from exercise of stock options	0	738
Equity investment by Holdings	0	0
Increase (decrease) in overdrafts	6,050	(7,916)
Proceeds from issuance of non-controlling interests	3,425	0
Distributions to and purchases of non-controlling interests	(5,251)	(286,641)
Net cash provided by (used in) financing activities	13,674	502,446
Net increase (decrease) in cash and cash equivalents	(27,363)	(2,866)
Cash and cash equivalents at beginning of period	175,178	122,549
Cash and cash equivalents at end of period	147,815	119,683
Supplemental Information
Cash paid for interest	37,199	35,233
Cash paid for taxes	718	376
Non-cash equity exchange for acquisition of U.S. HealthWorks	0	238,000
Select Medical Corporation
Operating activities
Net income	53,344	43,982
Adjustments to reconcile net income to net cash provided by operating activities:
Distributions from unconsolidated subsidiaries	7,872	1,364
Depreciation and amortization	52,138	46,771
Provision for bad debts	1,567	85
Equity in earnings of unconsolidated subsidiaries	(4,366)	(4,697)
Loss on extinguishment of debt	0	412
Gain on sale of assets and businesses	(6,233)	(513)
Stock compensation expense	6,255	4,927
Amortization of debt discount, premium and issuance costs	3,231	3,136
Deferred income taxes	(81)	78
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	(74,752)	(45,811)
Other current assets	(7,523)	(8,945)
Other assets	57,319	16,633
Accounts payable	4,324	(6,552)
Accrued expenses	(69,163)	(11,981)
Income taxes	17,830	11,838
Net cash provided by operating activities	41,762	50,727
Investing activities
Business combinations, net of cash acquired	(6,120)	(515,359)
Purchases of property and equipment	(49,073)	(39,617)
Investment in businesses	(27,608)	(1,754)
Proceeds from sale of assets and businesses	2	691
Net cash used in investing activities	(82,799)	(556,039)
Financing activities
Borrowings on revolving facilities	360,000	165,000
Payments on revolving facilities	(220,000)	(150,000)
Proceeds from term loans	0	779,904
Payments on term loans	(132,685)	(2,875)
Revolving facility debt issuance costs	0	(1,333)
Borrowings of other debt	8,290	11,600
Principal payments on other debt	(6,155)	(5,909)
Repurchase of common stock	0	0
Dividends paid to Holdings	0	(122)
Proceeds from exercise of stock options	0	0
Equity investment by Holdings	0	738
Increase (decrease) in overdrafts	6,050	(7,916)
Proceeds from issuance of non-controlling interests	3,425	0
Distributions to and purchases of non-controlling interests	(5,251)	(286,641)
Net cash provided by (used in) financing activities	13,674	502,446
Net increase (decrease) in cash and cash equivalents	(27,363)	(2,866)
Cash and cash equivalents at beginning of period	175,178	122,549
Cash and cash equivalents at end of period	147,815	119,683
Supplemental Information
Cash paid for interest	37,199	35,233
Cash paid for taxes	718	376
Non-cash equity exchange for acquisition of U.S. HealthWorks	$ 0	$ 238,000